QUALITY OF LIFE 60 DAYS AFTER AN ACUTE HEART FAILURE EVENT: INSIGHTS FROM THE PROTECT TRIAL

Methods Data on quality of life (QoL) was collected using the EQ5D instrument at 14 and 60 days after enrolment in a randomised controlled trial comparing rolofylline to placebo in patients with AHF (PROTECT) and plasma BNP >500pg/ml or NT-proBNP >2,000pg/ml.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2012-03, Vol.59 (13), p.E1032-E1032
Hauptverfasser:	Cleland, John, Chiswell, Karen, Filippatos, Gerasimos, Givertz, Michael, Massie, Barry, Cotter, Gad, Davison, Beth, Fiuzat, Mona, Voors, A.A, Mansoor, George, Ponikowski, Piotr, Teerlink, John, O'Connor, Christopher
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiology Cardiovascular Drug therapy Heart failure Internal Medicine Quality of life
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Methods Data on quality of life (QoL) was collected using the EQ5D instrument at 14 and 60 days after enrolment in a randomised controlled trial comparing rolofylline to placebo in patients with AHF (PROTECT) and plasma BNP >500pg/ml or NT-proBNP >2,000pg/ml.
ISSN:	0735-1097 1558-3597
DOI:	10.1016/S0735-1097(12)61033-X